TNR Diagnostics is a life sciences start-up which is focused on providing accurate and user-friendly in vitro tests for the rapid screening and characterization of genetic repeat disorders. The tests are based on innovative diagnostic solutions developed at the National University of Singapore (NUS). As an incubatee of The Biofactory, TNR Diagnostics was able to accelerate the development and launch of these novel in-vitro diagnostic kits.
TNR Diagnostics has developed FastFraX™ IVD kits for first-line screening and diagnosis of Fragile X Syndrome as well as FastDM1™ for Myotonic Dystrophy Type 1. The company is also exploring solutions for the screening and diagnosis of other genetic repeat disorders such as Huntington’s Disease.
Mr. Theodore Tan
Mr. Theodore Tan has nearly 15 years of experience in successfully marketing and distributing medical and diagnostics devices, as well as five years of experience in the development of medical devices. He is also the co-founder of Dyamed Biotech, a major supplier of diagnostic assays and test equipment to hospitals and labs in the Asia Pacific region.
Dr Guan Ming
Dr. Guan has 20 years of experience in the development of in-vitro diagnostic devices. Early in his career, he was involved in the research, development and commercialization of IVDDs locally for HIV and dengue detection. Thereafter he progressed to management roles in product manufacturing and operations. Prior to joining the Biofactory, Dr. Guan founded Becton Dickinson’s rapid diagnostics R&D centre in China.